NEUROONE MEDICAL TECHNOLOGIES Corp Contracts & Agreements
96 Contracts & Agreements
- Business Finance (55 contracts)
- Business Operations (6)
- Human Resources (7)
- Intellectual Property (4)
- Mergers & Acquisitions (1)
- Real Estate (1)
- Uncategorized (22)
- First Amendment to 2021 Inducement Plan (Filed With SEC on November 14, 2023)
- Employment Offer Letter, dated as of November 10, 2023, by and between Christopher Volker and the Company (Filed With SEC on November 14, 2023)
- Underwriting Agreement, dated July 24, 2023, between NeuroOne Medical Technologies Corporation and The Benchmark Company, LLC (Filed With SEC on July 27, 2023)
- Capital on Demand Sales Agreement, dated December 21, 2022 between NeuroOne Medical Technologies Corporation. and JonesTrading Institutional Services LLC (Filed With SEC on December 22, 2022)
- Amendment No. 3 to Exclusive Development and Distribution Agreement dated as of August 2, 2022 by and between the Company and Zimmer, Inc (Filed With SEC on August 11, 2022)
- Amendment No. 2 to Exclusive Development and Distribution Agreement dated as of July 1, 2022 by and between the Company and Zimmer, Inc (Filed With SEC on August 11, 2022)
- Warrant to Purchase Common Stock dated as of August 2, 2022 issued to Zimmer, Inc (Filed With SEC on August 11, 2022)
- Third Amendment to Exclusive Distribution and Development Agreement (Filed With SEC on August 3, 2022)
- Warrant to Purchase Common Stock (Filed With SEC on August 3, 2022)
- Amendment to Exclusive Development and Distribution Agreement by and between the Company and Zimmer, Inc. dated January 6, 2021 (Filed With SEC on December 15, 2021)
- Underwriting Agreement, dated October 13, 2021, between NeuroOne Medical Technologies Corporation and Craig-Hallum Capital Group LLC (Filed With SEC on October 14, 2021)
- Form of Stock Option Grant Notice, Option Agreement and Notice of Exercise under the NeuroOne Medical Technologies Corporation 2021 Inducement Plan (Filed With SEC on October 4, 2021)
- NeuroOne Medical Technologies Corporation 2021 Inducement Plan (Filed With SEC on October 4, 2021)
- Form of Purchase Agreement (Filed With SEC on January 15, 2021)
- Form of Warrant (Filed With SEC on January 15, 2021)
- Employment Offer Letter, dated as of January 1, 2021, by and between Ron McClurg and the Company (Filed With SEC on January 7, 2021)
- Securities Purchase Agreement (Filed With SEC on August 3, 2020)
- Exclusive Development and Distribution Agreement dated as of July 20, 2020 by and between NeuroOne and Zimmer (Filed With SEC on July 22, 2020)
- Form of Note (Filed With SEC on May 1, 2020)
- Form of Warrant (Filed With SEC on May 1, 2020)
- Form of Subscription Agreement (Filed With SEC on May 1, 2020)
- Form of Second Amendment (Filed With SEC on April 30, 2020)
- Form of Broker Warrant (Filed With SEC on January 24, 2020)
- Amended and Restated Exclusive Start-up Company License Agreement effective January 21, 2020 by and between NeuroOne Medical Technologies Corporation and Wisconsin Alumni Research... (Filed With SEC on January 24, 2020)
- Description of Securities (Filed With SEC on December 20, 2019)
- Lock-Up Agreement dated October 21, 2019, between Wade Fredrickson and the Company (Filed With SEC on December 20, 2019)
- Form of First Amendment to Convertible Promissory Note (Filed With SEC on December 11, 2019)
- Form of Note (Filed With SEC on November 7, 2019)
- Form of Warrant (Filed With SEC on November 7, 2019)
- Form of Subscription Agreement (Filed With SEC on November 7, 2019)
- Form of Securities Purchase Agreement (Filed With SEC on October 29, 2019)
- Lease Agreement dated October 7, 2019, by and among NeuroOne Medical Technologies Corporation and Biynah Cleveland, LLC, BIP Cleveland, LLC, and Edenvale Investors (Filed With SEC on October 11, 2019)
- Amendment to Exclusive Start-Up Company License Agreement by and between Wisconsin Alumni Research Foundation and the Company, dated September 18, 2019 (Filed With SEC on September 23, 2019)
- Form of HRA Warrant (Filed With SEC on July 5, 2019)
- Form of Paulson Warrant (Filed With SEC on July 5, 2019)
- Offer Letter between Steve Mertens and NeuroOne Medical Technologies Corporation, effective April 1, 2019 (Filed With SEC on May 10, 2019)
- Letter Agreement between the Company and Lifestyle Healthcare LLC, dated May 8, 2019 (Filed With SEC on May 8, 2019)
- Form of Warrant (issued in the Conversion) (Filed With SEC on March 6, 2019)
- Offer Letter between Scott Heuler and NeuroOne Medical Technologies Corporation, dated December 10, 2018 (Filed With SEC on February 11, 2019)
- Form of Purchase Agreement (Filed With SEC on January 4, 2019)
- Form of Warrant (Filed With SEC on January 4, 2019)
- Form of Registration Rights Agreement (Filed With SEC on January 4, 2019)
- First Amendment to Convertible Promissory Notes, dated as of December 31, 2018 (Filed With SEC on December 31, 2018)
- Promissory Note between the Company and Lifestyle Healthcare LLC, dated December 12, 2018 (Filed With SEC on December 18, 2018)
- Promissory Note between the Company and Jainal Bhuiyan, dated November 14, 2018 (Filed With SEC on November 20, 2018)
- Promissory Note between the Company and Lifestyle Healthcare LLC, dated November 14, 2018 (Filed With SEC on November 20, 2018)
- Description of compensatory arrangement with Thomas Bachinski (Filed With SEC on October 30, 2018)
- Amendment to Lock-up Agreement, dated as of July 17, 2018 by and between the Company and Wade Fredrickson (Filed With SEC on July 23, 2018)
- Form of Warrant (Filed With SEC on July 13, 2018)
- Form of Purchase Agreement (Filed With SEC on July 13, 2018)
- Form of Registration Rights Agreement (Filed With SEC on July 13, 2018)
- Form of Series 2 Notes Debt Conversion Agreement (Filed With SEC on July 6, 2018)
- Form of Series 1 Notes Debt Conversion Agreement (Filed With SEC on July 6, 2018)
- Promissory Note between the Company and Jainal Bhuiyan, dated May 17, 2018 (Filed With SEC on May 23, 2018)
- Promissory Note between the Company and Lifestyle Healthcare LLC, dated May 17, 2018 (Filed With SEC on May 23, 2018)
- Non-Employee Director Compensation Policy (Filed With SEC on April 16, 2018)
- Lock-up Agreement, effective as of March 1, 2018 by and between Wade Fredrickson and the Company (Filed With SEC on April 16, 2018)
- Form of Replacement Warrant (Filed With SEC on March 16, 2018)
- Form of Amended and Restated Note (Filed With SEC on March 16, 2018)
- Form of Additional Warrant (Filed With SEC on March 16, 2018)
- Form of Amended and Restated Subscription Agreement (Filed With SEC on December 20, 2017)
- Form of Amended and Restated Warrant (Filed With SEC on December 20, 2017)
- Form of Amended and Restated Note (Filed With SEC on December 20, 2017)
- First Amendment to Promissory Note by and between the Company and the Subscribers, dated as of November 30, 2017 (Filed With SEC on December 6, 2017)
- SECONDAMENDMENT TO CONVERTIBLE PROMISSORY NOTE (Filed With SEC on November 27, 2017)
- Form of Second Amendment to 2016 Warrant (Filed With SEC on November 27, 2017)
- Form of Subscription Agreement (Filed With SEC on October 6, 2017)
- Form of Warrant (Filed With SEC on October 6, 2017)
- Form of Note (Filed With SEC on October 6, 2017)
- SUBSCRIPTION AGREEMENT (Filed With SEC on August 23, 2017)
- NEUROONE MEDICAL TECHNOLOGIES CORPORATION CAPITAL STOCK PURCHASE WARRANT _________________ (Filed With SEC on August 23, 2017)
- NEUROONE MEDICAL TECHNOLOGIES CORPORATION PROMISSORY NOTE (Filed With SEC on August 23, 2017)
- EmploymentAgreement (Filed With SEC on August 7, 2017)
- Agreementand Plan of Merger and Reorganization By and among: NeuroOneMedical Technologies Corporation, a Delawarecorporation; OSOKAcquisition Company, a Delawarecorporation; and... (Filed With SEC on July 20, 2017)
- RESIGNATION LETTER July 20, 2017 (Filed With SEC on July 20, 2017)
- SeparationAND Release Agreement (Filed With SEC on July 20, 2017)
- EXCLUSIVE START-UP COMPANY LICENSEAGREEMENT (Filed With SEC on July 20, 2017)
- StockholdersAgreement of NeuroOne,Inc. (Filed With SEC on July 20, 2017)
- AMENDMENT TO EXCLUSIVE START-UPCOMPANY LICENSE AGREEMENT (Filed With SEC on July 20, 2017)
- MAYO FOUNDATION FOR MEDICAL EDUCATIONAND RESEARCH AMENDED AND RESTATED LICENSE AND DEVELOPMENTAGREEMENT (Filed With SEC on July 20, 2017)
- NeuroOne,Inc. SubscriptionAgreement (Filed With SEC on July 20, 2017)
- SUBSCRIPTION AGREEMENT (Filed With SEC on July 20, 2017)
- _______________________________ NEUROONE, INC. CONVERTIBLE PROMISSORY NOTE (Filed With SEC on July 20, 2017)
- FIRST AMENDMENT TO CONVERTIBLE PROMISSORY NOTES (Filed With SEC on July 20, 2017)
- WARRANT (Filed With SEC on July 20, 2017)
- FIRST AMENDMENT TO CAPITAL STOCK PURCHASEWARRANTS (Filed With SEC on July 20, 2017)
- NeuroOne,Inc. 14605Woodhaven Road Minnetonka,MN 55345 December 1, 2016 (Filed With SEC on July 20, 2017)
- NEUROONE, INC. 2016Equity Incentive Plan ADOPTEDBY THE BOARD OF DIRECTORS: October 20, 2016 APPROVED BY THE STOCKHOLDERS: October 20, 2016 TERMINATION DATE: October 20, 2026 (Filed With SEC on July 20, 2017)
- NEUROONE, INC. STOCK OPTION GRANT NOTICE (2016 Equity Incentive Plan) (Filed With SEC on July 20, 2017)
- RESTRICTED STOCKPURCHASE AGREEMENT (Filed With SEC on July 20, 2017)
- NEUROONE MEDICAL TECHNOLOGIES CORPORATION STOCK OPTION GRANT NOTICE (2017 EQUITY INCENTIVE PLAN) (Filed With SEC on July 20, 2017)
- NEUROONE MEDICAL TECHNOLOGIES CORPORATION RESTRICTED STOCK UNIT GRANT NOTICE (2017 EQUITY INCENTIVE PLAN) (Filed With SEC on July 20, 2017)
- EmploymentAgreement (Filed With SEC on July 20, 2017)
- NeuroOne,Inc. 14605Woodhaven Road Minnetonka,MN 55345 December 1, 2016 (Filed With SEC on July 20, 2017)
- NeuroOne,Inc. 14605Woodhaven Road Minnetonka,MN 55345 January 9, 2017 (Filed With SEC on July 20, 2017)
- Planof Conversion PLAN OF CONVERSION OF NEUROONE MEDICAL TECHNOLOGIES CORPORATION, A NEVADA CORPORATION INTO NEUROONE MEDICAL TECHNOLOGIES CORPORATION, A DELAWARE CORPORATION (Filed With SEC on June 29, 2017)